Kaplan Meier failure curve, all patients.

<p>Kaplan Meier failure curve, all patients.</p

Cox regression exploring clinical and social risk factors for death, by HIV serostatus.

<p>* Adjusted for oedema, age, sex, admission WAZ and admission MUAC.</p

Patient profile at baseline (initial admission), by final outcome.

†<p>Numbers with kwashiorkor plus numbers with severe wasting = 972 rather than 1024: the remaining 52 patients had complicated moderate wasting. These children were treated according to exactly the same protocols as those with SAM and hence are included in the follow-up study.</p

FuSAM study flow chart - all admissions to MOYO.

<p>(OTP = ‘Outpatient Treatment Programme’ – the outpatient part of treatment; T/F = transfer out to different programme). ‘Still sick’ children were seen or reported to be clinically unwell at follow-up but details were not always known.</p

Kaplan Meier failure curves, by HIV serostatus.

<p>The tables below <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0096030#pone-0096030-g002" target="_blank">figures 2</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0096030#pone-0096030-g003" target="_blank">3</a> show numbers at risk at the beginning of a particular time period. Deaths are in parentheses. Numbers at risk are not simply those previous at-risk minus deaths. Other outcomes also result in children being removed from further analysis (being ‘censored’). With this denominator change, the y-axis is mortality <i>probability</i> rather than percentage. Whilst our main outcomes focus is on the first year post-discharge, for completeness, data is presented until the last child's follow-up.</p

Boxplot showing weight-for-height, weight-for-age and height-for-age of the ex-malnourished surviving child (M) (n = 386) compared to sibling controls (S) (n = 277).

<p>Boxplot showing weight-for-height, weight-for-age and height-for-age of the ex-malnourished surviving child (M) (n = 386) compared to sibling controls (S) (n = 277).</p

Cox regression exploring main baseline predictors of death.

<p>* Adjusted for age, oedema, and HIV status.</p

Regression analysis of mean height for age and stunting prevalence (HAZ<-2) in children aged 6–59 months.

<p>Regression analysis of mean height for age and stunting prevalence (HAZ<-2) in children aged 6–59 months.</p

Regression analysis of mean haemoglobin and the prevalence of anaemia at baseline and end-line in children aged 6–23 months.

<p>Regression analysis of mean haemoglobin and the prevalence of anaemia at baseline and end-line in children aged 6–23 months.</p

Regression analysis of mean haemoglobin and the prevalence of anaemia at baseline and end-line in children aged 6–59 months.

<p>Regression analysis of mean haemoglobin and the prevalence of anaemia at baseline and end-line in children aged 6–59 months.</p